(Q46458603)

22 December 2017

meta-analysis

0 references

title

Serum Iron, Zinc, and Copper Levels in Patients with Alzheimer's Disease: A Replication Study and Meta-Analyses (English)

1 reference

22 December 2017

0 references

0 references

Jin-Tai Yu

10

0 references

Lan Tan

2

object named as

Lan Tan

1 reference

22 December 2017

9

Teng Jiang

1 reference

22 December 2017

Jia-Hao Sun

7

object named as

Jia-Hao Sun

1 reference

22 December 2017

author name string

Zi-Xuan Wang

1

1 reference

22 December 2017

Hui-Fu Wang

3

1 reference

22 December 2017

Jing Ma

4

1 reference

22 December 2017

Jinyuan Liu

5

1 reference

22 December 2017

Meng-Shan Tan

6

1 reference

22 December 2017

Xi-Chen Zhu

8

1 reference

22 December 2017

publication date

1 August 2015

1 reference

22 December 2017

Journal of Alzheimer's Disease

published in

1 reference

22 December 2017

volume

47

1 reference

22 December 2017

issue

3

1 reference

22 December 2017

page(s)

565-581

1 reference

22 December 2017

Metallostasis in Alzheimer's disease.

cites work

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Metal dyshomeostasis and oxidative stress in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Zinc in Alzheimer's Disease: A Meta-Analysis of Serum, Plasma, and Cerebrospinal Fluid Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Oxidative stress in blood in Alzheimer's disease and mild cognitive impairment: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Methods for exploring heterogeneity in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Meta-analysis: principles and procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Determination of selected trace elements in patients affected by dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Elevation of serum copper levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

d-penicillamine reduces serum oxidative stress in Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Trace elements and cognitive impairment: an elderly cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum chemical elements and oxidative status in Alzheimer's disease, Parkinson disease and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum zinc is decreased in Alzheimer's disease and serum arsenic correlates positively with cognitive ability

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Ceruloplasmin and iron proteins in the serum of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Effects of hemochromatosis and transferrin gene mutations on iron dyshomeostasis, liver dysfunction and on the risk of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Potential blood biomarker for disease severity in the Taiwanese population with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Metal-score as a potential non-invasive diagnostic test for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Polymorphism in Cytochrome P450 2D6, Glutathione S-Transferases Pi 1 Genes, and Organochlorine Pesticides in Alzheimer Disease: A Case-Control Study in North Indian Population.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Characterization of metal profiles in serum during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Homeostasis of metals in the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

'Free' copper in serum of Alzheimer's disease patients correlates with markers of liver function

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Genetic and biochemical markers in patients with Alzheimer's disease support a concerted systemic iron homeostasis dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum multivalent cationic pattern: speculation on the efficient approach for detection of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Lipid peroxidation and free radical scavengers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Inflammatory markers in younger vs elderly normal volunteers and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum zinc, copper, insulin and lipids in Alzheimer's disease epsilon 4 apolipoprotein E allele carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Decreased serum zinc is an effect of ageing and not Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum zinc levels and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Subclinical zinc deficiency in Alzheimer's disease and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Ceruloplasmin fragmentation is implicated in 'free' copper deregulation of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Speciation analysis of selected metals and determination of their total contents in paired serum and cerebrospinal fluid samples: An approach to investigate the permeability of the human blood-cerebrospinal fluid-barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Free copper and resting temporal EEG rhythms correlate across healthy, mild cognitive impairment, and Alzheimer's disease subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Excess of serum copper not related to ceruloplasmin in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Serum copper in Alzheimer's disease and vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Copper and ceruloplasmin abnormalities in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Elevated serum copper and ceruloplasmin levels in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Role of iron in Alzheimer-type dementia in Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

CSF Mg and Ca as diagnostic markers for dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Metal concentrations in plasma and cerebrospinal fluid in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Alterations of plasma magnesium, copper, zinc, iron and selenium concentrations and some related erythrocyte antioxidant enzyme activities in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Rapid induction of Alzheimer A beta amyloid formation by zinc.

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Wilson's disease: the importance of measuring serum caeruloplasmin non-immunologically

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Copper, beta-amyloid, and Alzheimer's disease: tapping a sensitive connection

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Clioquinol mediates copper uptake and counteracts copper efflux activities of the amyloid precursor protein of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

A relaxing factor in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3233%2FJAD-143108

21 January 2018

Identifiers

DOI

10.3233/JAD-143108

1 reference

22 December 2017

PubMed ID

26401693

1 reference

22 December 2017